Cost-free Access to AI Platform to Help Academic Medical Centers and Research Institutions Continue Crucial Programs During Funding Shortfalls NEW...
AUSTIN, Texas, Sept. 15, 2025 /PRNewswire/ -- Emporia Research, a leader in B2B research participant recruitment, today announced the expansion...
Oova's platform now offers 15 hormone pattern classifications and reproductive staging capabilities based on 30,000+ cycle analysis NEW YORK, Sept....
ALBANY, N.Y., Sept. 15, 2025 /PRNewswire/ -- The New York StateWide Senior Action Council (StateWide), a 53-year-old non-profit organization dedicated...
Seasoned Venture Capital and Healthcare Technology Executive Joins As Two Bear CapitalRaises Second Fund WHITEFISH, Mont., Sept. 15, 2025 /PRNewswire/...
Preeminent SOL-backed treasury vehicle - with potential to deliver over $1.25 billion - unlocks capital markets to accelerate Solana's growth...
NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Aegis Ventures announced three health systems– Yale New Haven Health System, Keck Medicine of...
Definitive agreement to accelerate adoption of Renalytix's FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient...
New program sets national standards for ethical and trustworthy AI use in patient care WASHINGTON, Sept. 15, 2025 /PRNewswire/ --...
ORLANDO, FL / ACCESS Newswire / September 15, 2025 / The Assistance Fund (TAF), an independent charitable patient assistance organization...
OMAHA, NE / ACCESS Newswire / September 15, 2025 / PAO Group, Inc. (OTC:PAOG), today announced the appointment of James...
NEWARK, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that data...
Latest patent award strengthens competitive moat and reinforces leadership in medical navigation technologyTYLER, Texas--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV) (“NanoVibronix” or...
-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump SAN DIEGO, CA / ACCESS Newswire / September...
Black Book Insights' global survey of 404 executives across 40 countries forecasts USD 65 billion in annual non-U.S. payer IT...
Current XanaMIA pivotal phase 2/3 trial on track for interim analysis in January 2026 and final results late 2026 with...
PHILADELPHIA, Sept. 15, 2025 /PRNewswire/ -- InvisALERT Solutions' ObservSMART, the industry-leading proximity-required technology designed to improve staff and patient safety...
Nationwide initiative pairs eligible college athletes with trusted LASIK surgeons and a compliant, content‑first partnership model AUSTIN, TX / ACCESS...
BREA, CALIFORNIA / ACCESS Newswire / September 15, 2025 / Kerr is excited to announce the launch of SimpliCore™, a...
"By throwing out the DEA's Biden marijuana mess, President Trump opened the door for real medicine - MMJ's FDA cannabis...